Issue 3
-
Immunodeficiency should not be a stranger to rheumatologists
“A better way to think about immunodeficiency is as immune dysregulation. It is paradoxical, but many patients with immunodeficiencies are also at increased risk for autoimmunity and for granuloma formation,”” said Mahta Mortezavi, MD.
-
Molecular-level advances lead to improved understanding of vasculitis
New technologies make it possible to measure tens of thousands of cells at once, giving researchers an opportunity for improving our understanding of disease on a molecular level.
-
Gout concerns extend to several different types of comorbidities
A Monday afternoon Clinical Practice session will examine several comorbidities that can complicate management and affect longterm prognoses for patients.
-
Pediatric rheumatologists stress importance of early recognition of juvenile localized scleroderma
“There is a great need to recognize when to treat this disease, because, as with many of our other rheumatic diseases, there’s a window of opportunity,” said Suzanne Li, MD, PhD.
-
Expert panel to review current myositis recommendations
Recent and ongoing research continues to increase understanding of the underlying mechanisms of myositis, providing important groundwork for the development of new diagnostic and screening tools and novel